Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth - Oklahoma and Texas, 2015

Martha Kapaya, Denise V D'Angelo, Van T Tong, Lucinda England, Nan Ruffo, Shanna Cox, Lee Warner, Jennifer Bombard, Tanya Guthrie, Ayesha Lampkins, Brian A King, Martha Kapaya, Denise V D'Angelo, Van T Tong, Lucinda England, Nan Ruffo, Shanna Cox, Lee Warner, Jennifer Bombard, Tanya Guthrie, Ayesha Lampkins, Brian A King

Abstract

Electronic vapor products (EVPs) comprise a diverse group of devices, including electronic cigarettes (e-cigarettes). EVP users inhale an aerosol that typically contains nicotine, flavorings, and other additives (1). Nicotine is a developmental toxicant that adversely affects pregnancy and infant outcomes (2). Data from the 2015 Pregnancy Risk Assessment Monitoring System (PRAMS) for Oklahoma and Texas were analyzed to estimate population-based EVP use among women with a recent live birth. EVP use before pregnancy (defined as >3 months before pregnancy) and around the time of pregnancy (defined as any time during the 3 months before pregnancy, the last 3 months of pregnancy, or 2-6 months after delivery), reasons for EVP use, and dual use of EVPs and cigarettes were assessed. Prevalence of EVP use was 10.4% before pregnancy and 7.0% around the time of pregnancy, including 1.4% during the last 3 months of pregnancy. Among women using EVPs during the last 3 months of pregnancy, 38.4% reported use of EVPs containing nicotine, and 26.4% were unsure of nicotine content. Among women who had used EVPs and cigarettes, dual use prevalence was 38.0% in the 3 months before pregnancy, 7.7% during the last 3 months of pregnancy, and 11.8% in the 2-6 months after delivery. The most frequently reported reasons for EVP use around the time of pregnancy were curiosity (54.0%), the perception that EVPs might help with quitting or reducing cigarette smoking (45.2%), and the perception of reduced harm to the mother, when compared with cigarette smoking (45.2%). Clear messages that EVP use is not safe during pregnancy are needed, and broad, barrier-free access to evidence-based tobacco cessation strategies need to be made available.

Conflict of interest statement

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

Figure 1
Figure 1
Percentage of women using electronic vapor products (EVPs) and cigarettes 3 months before pregnancy, during the last 3 months of pregnancy, or 2–6 months after delivery, among women with a recent live birth who smoked cigarettes in the last 2 years and ever used EVPs (N = 518) — Pregnancy Risk Assessment Monitoring System, Oklahoma and Texas, 2015
Figure 2
Figure 2
Percentage of women with a recent live birth who reported a reason for using electronic vapor products (EVPs) >3 months before pregnancy (even once) and around the time of pregnancy, by most frequently reported reasons — Pregnancy Risk Assessment Monitoring System, Oklahoma and Texas, 2015 * Around the time of pregnancy includes 3 months before pregnancy, during last 3 months of pregnancy, or 2–6 months after delivery.

References

    1. US Department of Health and Human Services. E-cigarette use among youth and young adults: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, CDC; 2016.
    1. American College of Obstetricians and Gynecologists. Committee opinion no. 721: smoking cessation during pregnancy. Obstet Gynecol 2017;130:e200–4. 10.1097/AOG.0000000000002353
    1. Kurti AN, Redner R, Lopez AA, et al. Tobacco and nicotine delivery product use in a national sample of pregnant women. Prev Med 2017;104:50–6. 10.1016/j.ypmed.2017.07.030
    1. Wagner NJ, Camerota M, Propper C. Prevalence and perceptions of electronic cigarette use during pregnancy. Matern Child Health J 2017;21:1655–61. 10.1007/s10995-016-2257-9
    1. Oncken C, Ricci KA, Kuo CL, Dornelas E, Kranzler HR, Sankey HZ. Correlates of electronic cigarettes use before and during pregnancy. Nicotine Tob Res 2017;19:585–90. 10.1093/ntr/ntw225
    1. National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018.
    1. Marynak KL, Gammon DG, Rogers T, Coats EM, Singh T, King BA. Sales of nicotine-containing electronic cigarette products: United States, 2015. Am J Public Health 2017;107:702–5. 10.2105/AJPH.2017.303660
    1. US Preventive Services Task Force. Tobacco smoking cessation in adults, including pregnant women: behavioral and pharmacotherapy interventions. Rockville, MD: US Preventive Services Task Force; 2015.
    1. King BA, Gammon DG, Marynak KL, Rogers T. Electronic cigarettes sales in the United States, 2013–2017. JAMA 2018;320:1379–80. 10.1001/jama.2018.10488

Source: PubMed

3
Abonnieren